TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
BWT Pharma & Biotech AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 222,081 | 147,667 | 151,033 |
Financial expenses | 30 | 31 | 4 |
Earnings before taxes | 32,238 | 17,739 | 1,302 |
EBITDA | 32,467 | 18,085 | 1,612 |
Total assets | 135,346 | 103,976 | 75,707 |
Current assets | 134,345 | 102,765 | 74,391 |
Current liabilities | 92,928 | 61,641 | 48,683 |
Equity capital | 35,562 | 25,631 | 11,887 |
- share capital | 334 | 364 | 371 |
Employees (average) | 42 | 37 | 28 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 26.3% | 24.7% | 15.7% |
Turnover per employee | 5,288 | 3,991 | 5,394 |
Profit as a percentage of turnover | 14.5% | 12.0% | 0.9% |
Return on assets (ROA) | 23.8% | 17.1% | 1.7% |
Current ratio | 144.6% | 166.7% | 152.8% |
Return on equity (ROE) | 90.7% | 69.2% | 11.0% |
Change turnover | 86,374 | -507 | 16,704 |
Change turnover % | 64% | 0% | 12% |
Chg. No. of employees | 5 | 9 | 5 |
Chg. No. of employees % | 14% | 32% | 22% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.